A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease
Status:
Terminated
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and tolerability of cisapride with
placebo in infants and children with gastro-oesophageal reflux disease (GORD).
Phase:
Phase 4
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.